These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32738490)

  • 41. Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19".
    Atkinson JG
    Int J Infect Dis; 2020 Oct; 99():37. PubMed ID: 32738492
    [No Abstract]   [Full Text] [Related]  

  • 42. Does Combining Severe and Mild Cases of COVID-19 Produce Low Fatality Rates After Treatment With Hydroxychloroquine and Azithromycin?
    Fleury V
    Am J Epidemiol; 2020 Nov; 189(11):1227-1229. PubMed ID: 32685969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
    Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
    Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
    [No Abstract]   [Full Text] [Related]  

  • 44. Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
    Dar SA; Wahid M; Haque S; Almalki SS; Akhter N
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7923-7924. PubMed ID: 32767316
    [No Abstract]   [Full Text] [Related]  

  • 45. Flexibilization of Science, Cognitive Biases, and the COVID-19 Pandemic.
    Oliveira J E Silva L; Vidor MV; Zarpellon de Araújo V; Bellolio F
    Mayo Clin Proc; 2020 Sep; 95(9):1842-1844. PubMed ID: 32861327
    [No Abstract]   [Full Text] [Related]  

  • 46. Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19.
    Rosenberg ES; Holtgrave DR; Udo T
    Int J Infect Dis; 2020 Oct; 99():38-39. PubMed ID: 32738483
    [No Abstract]   [Full Text] [Related]  

  • 47. Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
    Varisco TJ; Johnson ML; Thornton D
    Int J Infect Dis; 2020 Oct; 99():373. PubMed ID: 32771630
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
    Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
    [No Abstract]   [Full Text] [Related]  

  • 49. Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
    d'Arminio Monforte A; Tavelli A; Bai F; Marchetti G; Cozzi-Lepri A
    Int J Infect Dis; 2020 Oct; 99():75-76. PubMed ID: 32738491
    [No Abstract]   [Full Text] [Related]  

  • 50. Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients.
    Brito-Azevedo A
    Int J Infect Dis; 2020 Oct; 99():324. PubMed ID: 32768698
    [No Abstract]   [Full Text] [Related]  

  • 51. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
    Gautret P; Lagier JC; Parola P; Hoang VT; Meddeb L; Mailhe M; Doudier B; Courjon J; Giordanengo V; Vieira VE; Tissot Dupont H; Honoré S; Colson P; Chabrière E; La Scola B; Rolain JM; Brouqui P; Raoult D
    Int J Antimicrob Agents; 2020 Jul; 56(1):105949. PubMed ID: 32205204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risch Responds to "How to Consider Low Reported Death Rates in COVID-19".
    Risch HA
    Am J Epidemiol; 2020 Nov; 189(11):1230-1231. PubMed ID: 32685962
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
    Yazdany J; Kim AHJ
    Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
    D'Acquarica I; Agranat I
    Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
    [No Abstract]   [Full Text] [Related]  

  • 55. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
    Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
    Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
    [No Abstract]   [Full Text] [Related]  

  • 56. COVID-19 and hydroxychloroquine: Let the available data speak for themselves.
    Paliani U; Cardona A
    Eur J Intern Med; 2020 Oct; 80():121. PubMed ID: 32709544
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacist's perspective on HCQ treatment of COVID-19.
    Wang YL; Wang SH; Yang AY
    Kaohsiung J Med Sci; 2020 Aug; 36(8):660. PubMed ID: 32533592
    [No Abstract]   [Full Text] [Related]  

  • 58. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
    Schluger NW
    Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Possible synergistic effects of hydroxychloroquine and steroids in COVID-19, time for a nuanced approach. Comment on Arshad et al.
    Wiseman DM
    Int J Infect Dis; 2020 Oct; 99():344-345. PubMed ID: 32768694
    [No Abstract]   [Full Text] [Related]  

  • 60. Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.
    de Miranda Santos IKF; Costa CHN
    Front Immunol; 2020; 11():1739. PubMed ID: 32849619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.